Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RIVASTIGMINE
- A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.
- Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h)
- Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)
- Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
- Effect of Hydralazine on Alzheimer's Disease
- The Effect of Donepezil on Glycemic Control in Type II Diabetics
- The Effect of Donepezil on Wound Healing
- CHIEF PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)
- Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium
- Noradrenaline, Acetylcholine and Dynamic Learning in Healthy Humans
- Effect of Heat on Rivastigmine TDS Products
- Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease
- Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)
- Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase
- Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease
- Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease
- Noradrenergic Add-on Therapy With Guanfacine
- Detecting an Early Response to Donepezil With Measures of Visual Attention
- A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
- Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy
- NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.
- Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
- Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.
- Pharmacovigilance in Gerontopsychiatric Patients
- The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
- Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
- Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
- Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
- 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
- The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease
- Masitinib in Patients With Mild to Moderate Alzheimer's Disease
- Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease
- Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine
- A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
- Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
- Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
- Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)
- Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients
- Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
- Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
- Mild Cognitive Impairment in Parkinson's Disease
- Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
- Rivastigmine in the Management of Delirium
- Cilostazol Augmentation Study in Dementia
- A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
- Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine
- Comparative Research of Alzheimer's Disease Drugs
- Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
- Cognitive Decline in Non-demented PD
- Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients
- Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients
- Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions
- Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions
- Rivastigmine Study in Adolescents With Down Syndrome
- Rivastigmine as a Treatment for Methamphetamine Dependence
- A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
- Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
- Exelon Patch and Combination With Memantine Comparative Trial
- Clinical Trial of Donepezil Between the Naive Group and the Switching Group
- The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
- Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease
- Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
- Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
- Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial
- Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
- Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
- Efficacy of Rivastigmine in Patients With Down Syndrome
- Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
- Rivastigmine for Intensive Care Unit (ICU) Delirium
- RIVastigmine In Vascular cognitivE Impairment
- Rivastigmine in Mild Alzheimer's Disease, FMRI Study
- A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers
- Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
- A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
- Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients
- Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
- Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
- Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy
- Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
- Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
- Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
- Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
- Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
- Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
- Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
- An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits
- An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
- Donepezil Treatment of Psychotic Symptoms in Dementia Patients
- Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment
- Rivastigmine For Methamphetamine Dependent Individuals
- Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease
- Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
- Rivastigmine Capsules in Patients With Probable Vascular Dementia
- Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
- Neuromodulation and Language Acquisition (Stage Ib)
- Neuromodulation and Language Acquisition (Project Stage Ia)
- Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
- Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia
- Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
Clinical trials list
click for details